Embolic Selection and Techniques in the Management of Endoleaks, Pulmonary AVMs and Aneurysms: A Case-Based Presentation

Embolic Selection and Techniques in the Management of Endoleaks, Pulmonary AVMs and Aneurysms: A Case-Based Presentation

On-Demand Webcast

 

This webcast is based on live proceedings from the 2018 ISET/CIO conference.

Faculty

Ripal Gandhi, MD, FSVM
Associate Clinical Professor
Florida International University,
Herbert Wertheim College of Medicine
Miami Cardiac & Vascular Institute
Miami, Florida

Ziv J. Haskal, MD, FSIR, FAHA, FACR, FCIRSE
Professor and Radiology Fellowship Director
Interventional Radiology
University of Virginia School of Medicine
Editor in Chief, Journal of Vascular and Interventional Radiology
Charlottesville, Virginia

Brian Schirf, MD
Interventional Radiology
Riverside Radiology and Interventional Associates
Columbus, Ohio

Clifford Weiss, MD
Interventional Radiology
The Johns Hopkins University School of Medicine
Baltimore, Maryland

PROVIDER STATEMENT

 Provided by North American Center for Continuing Medical Education, LLC, an HMP Company.

For questions regarding this educational activity, please call 609-371-1137 or email info@naccme.com.

INTENDED LEARNERS

This activity is designed is designed for interventional radiologists, surgeons, oncologists, and other healthcare professionals involved in the treatment of cancer or looking to expand into this arena.

LEARNING OBJECTIVES

Upon completion of this activity, participants should be able to:

  • Identify best possible embolic agent based on disease diagnosis and patient presentation
  • Compare and contrast risks associated with various embolic agents
  • Analyze patient cases that illustrate the management of endoleaks, pulmonary AVMs and aneurysms to better apply the method of selection of embolic agents in daily practice
CLAIMING CREDIT

To be eligible for credit, participants must view the webinar, complete the online activity, the post-test assessment, and the evaluation by March 31, 2021. Upon completing the activity, there will be instructions on how to print a certificate or other documentation of credit.

Release Date: March 2, 2018
Expiration Date: March 31, 2021
Estimated time to complete: .75 hour

There is no fee associated with this activity.

COMMERCIAL SUPPORT

NACCME would like to thank the following company who has supported the "Embolic Selection and Techniques in the Management of Endoleaks, Pulmonary AVMs and Aneurysms: A Case-Based Presentation" through educational grants and/or in-kind support: Medtronic

CONTINUING EDUCATION

   In support of improving patient care, NACCME is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team.

Save

PHYSICIANS

NACCME designates this enduring activity for a maximum of .75 AMA PRA Category 1 Credit™.Physicians should claim only the credit commensurate with the extent of their participation in the activity.

NURSING

This continuing nursing education activity awards .75 contact hour.

Provider approved by the California Board of Registered Nursing, Provider #13255 for .75 contact hour.

PHYSICIAN ASSISTANTS

NACCME has been authorized by the American Academy of PAs (AAPA) to award AAPA Category 1.00 CME credit for activities planned in accordance with the AAPA CME Criteria. This activity is designated for .75 AAPA Category 1 credit. PAs should only claim credit commensurate with the extent of their participation.

VASCULAR & INTERVENTIONAL RADIOGRAPHERS

Embolic Selection and Techniques in the Management of Endoleaks, Pulmonary AVMs and Aneurysms: A Case-Based Presentation, taking place on DAY, DATE from TIME has been approved for .75 A+ ARRT CE credits by the Association for Vascular and Interventional Radiographers (AVIR). The AVIR is an ARRT Recognized Continuing Education Evaluating Mechanism, (RCEEM).

USE OF PROPRIETARY NAMES

This continuing medical education activity may include device or medicine brand names for participant clarity purposes only, due to the presence of different branded versions of the same product. No product promotion or recommendation should be inferred.

UNAPPROVED AND/OR INVESTIGATIONAL USES OF DRUGS AND DEVICES

This activity may contain information about experimental and other uses of drugs or devices that are not currently approved by the European Medicines Agency (EMA) of the European Union or the Food and Drug Administration (FDA) of the United States. Participants are strongly encouraged to consult approved product labeling for any drug or device mentioned in this activity before use. The opinions expressed during this activity are the opinions of the respective authors, presenters or moderators and do not necessarily reflect the opinions of NACCME.

DISCLAIMERS

The material presented and related discussions are not intended to be medical advice, and the presentation or discussion of such material is not intended to create and does not establish a physician-patient relationship. Medical advice of any nature should be sought from an individual’s own physician.

Neither NACCME nor any of its subsidiaries or affiliates is affiliated with, or formally endorsed by a medical society.

The opinions expressed in this educational activity are those of the faculty and are not attributable to NACCME or HMP. Clinical judgment must guide each professional in weighing the benefits of treatment against the risk of toxicity. Dosages, indications, and methods of use for products referred to in this activity are not necessarily the same as indicated in the package insert for each product, may reflect the clinical experience of the presenters, and may be derived from the professional literature or other clinical sources. Consult complete prescribing information before administering.

DISCLOSURE OF RELEVANT FINANCIAL RELATIONSHIPS

NACCME, LLC is an independent provider(s) of continuing medical education. NACCME, LLC has no proprietary or financial interest in medical or healthcare products over which the FDA (USA) or EMA (EU) has regulatory authority.

NACCME, LLC assures that all educational materials are reviewed to ensure for the absence of commercial bias, fair balance, scientific objectivity, and levels of evidence. The educational activity will not be influenced by commercial organizations and will not conflict with any other scheduled educational activities.

According to the disclosure policy of NACCME, faculty, editors, managers, and other individuals who are in a position to control content are required to disclose any relevant financial relationships with relevant commercial companies related to this activity. All relevant conflicts of interest that are identified are reviewed for potential conflicts of interest. If a conflict is identified, it is the responsibility of NACCME to initiate a mechanism to resolve the conflict. The existence of these interests or relationships is not viewed as implying bias or decreasing the value of the presentation.

Clinical Reviewer:

Robert S. Dieter, MD, RVT, FACC
Professor
Loyola University Medicine
Chicago, Illinois

Nurse Planner: Susie Seaman, NP, MSN, CWOCN, Infectious Disease Consultants/San Diego Infusion Center, San Diego, CA

Planning Committee

In addition to the faculty listed below, NACCME planners and staff include Chris Bowell, Samantha Conforti, Randy Robbin, Margie Stefan and Colleen Waters.

Mr. Bolwell is a shareholder of GlaxoSmithKline. GlaxoSmithKline is not supporting this activity, nor does any content relate to their product/service.

The faculty has reported the following:

Dr. Gandhi: Consultant—Bard, BTG, Gore, Medtronic, Merit, Penumbra  

Dr. Haskal: Consultant/Speaker Bureau—Medtronic, CR Bard, WL Gore, Boston Scientific, Bendit; Research support—Teclison, Sequana

Dr. Schirf: Consultant—Medtronic

Dr. Weiss: Consultant—BTG, Medtronic; Grant/Research Support—BTG, Merit Medical, Siemens Healthcare, NIH

Ms. Seaman: Speakers' Bureau—Next Science

Dr. Dieter has disclosed no relevant financial relationships with any commercial interests.

ADA STATEMENT

North American Center for Continuing Medical Education (NACCME) complies with the legal requirements of the Americans with Disabilities Act and the rules and regulations thereof. If any participant in this educational activity is in need of accommodations, please call 609-371-1137.

Privacy Policy

NACCME protects the privacy of personal and other information regarding participants, educational partners, and joint providers. NACCME and our joint providers will not release personally identifiable information to a third party without the individual’s consent, except such information as is required for reporting purposes to the appropriate accrediting agency. NACCME maintains physical, electronic, and procedural safeguards that comply with federal regulations to guard your nonpublic personal information.

Copyright © 2020 by North American Center for Continuing Medical Education, LLC. All rights reserved. No part of this accredited continuing education activity may be reproduced or transmitted in any form or by any means, electronic or mechanical, without first obtaining permission from North American Center for Continuing Medical Education.